文献速递糖尿病肥胖与代谢综合征

吲哚经胃肠道改善糖尿病小鼠血糖稳态

The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis in a mouse model of diabetes by enhancing GLP-1 secretion and L cell differentiation.
PubMed 文献 · Diabetologia · 2026-03-04

该研究探讨微生物色氨酸代谢物吲哚是否通过胃肠道调节血糖稳态。体外实验显示吲哚浓度依赖性刺激GLP-1分泌,小鼠体内实验显示吲哚改善急性血糖管理并促进L细胞分化,亚慢性给药改善糖尿病小鼠糖耐量和胰岛素敏感性。

要点

  • 吲哚浓度依赖性刺激肠内分泌细胞GLP-1分泌。
  • 吲哚促进小鼠回肠类器官L细胞分化,增加L细胞密度。
  • 亚慢性吲哚给药改善糖尿病小鼠糖耐量和胰岛素敏感性。

核心结论

  • 吲哚是作用于肠道、降低血糖的分子。
  • 吲哚可能作为营养补充剂用于2型糖尿病的治疗或预防。

研究设计与样本

  • 体外培养小鼠肠内分泌细胞测定GLP-1分泌。
  • 小鼠体内评估腹腔葡萄糖耐量和激素分泌。
  • 小鼠回肠类器官培养和体内实验检查肠上皮细胞命运和L细胞数量。
  • 在2型糖尿病小鼠模型中探索亚慢性吲哚给药的代谢结局。

主要发现

  • 吲哚浓度依赖性刺激体外GLP-1分泌。
  • 吲哚改善小鼠急性血糖管理。
  • 吲哚驱动小鼠回肠类器官肠内分泌L细胞分化,增加L细胞密度并在体内产生更长期血糖调节益处。
  • 亚慢性吲哚给药改善糖尿病小鼠模型的糖耐量和胰岛素敏感性。

临床怎么用

  • 提示吲哚可能作为营养补充剂用于2型糖尿病治疗或预防。
  • 强调肠道菌群代谢物在代谢健康中的重要性。

局限性

  • 研究基于小鼠模型和体外细胞/类器官,人体应用需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Growing evidence implicates gut microbiota-derived metabolites in metabolic homeostasis. Indole, a microbial tryptophan metabolite, has been reported to enhance glucagon-like peptide-1 (GLP-1) secretion in vitro, and its derivatives have been inversely associated with risk of type 2 diabetes. We hypothesised that indole acts via the gastrointestinal tract to modulate glucose homeostasis, and tested this hypothesis using in vitro and in vivo models. METHODS: We measured GLP-1 secretion from cultured murine enteroendocrine cells, and evaluated intraperitoneal glucose tolerance and hormone secretion in mice following indole treatment. Subsequently, the impact of indole on intestinal epithelial cell fate and L cell number was examined using murine ileal organoid cultures and in vivo. Finally, we explored the effect of chronic indole administration on metabolic outcomes in a murine model of type 2 diabetes. RESULTS: Indole stimulated in vitro GLP-1 secretion in a concentration-dependent manner, and improved acute glucose management in vivo. Additionally, we demonstrate that indole drives enteroendocrine L cell differentiation in murine ileal organoids, resulting in increased L cell density and longer-term glucoregulatory benefits in vivo. Finally, sub-chronic indole administration improved glucose tolerance and insulin sensitivity in a diabetic mouse model. CONCLUSIONS/INTERPRETATION: Our findings identify indole as a glucose-lowering molecule that acts on the gut, and raise the possibility of incorporating indole into nutraceutical supplements to aid in the treatment or prevention of type 2 diabetes. This study highlights the importance of gut microbiota-derived metabolites in metabolic health and opens new avenues for developing novel strategies to combat type 2 diabetes. DATA AVAILABILITY: RNA sequencing data are available from the Gene Expression Omnibus under accession number GSE306720.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Phuah P, Norton M, Cheng S, et al. The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis in a mouse model of diabetes by enhancing GLP-1 secretion and L cell differentiation. Diabetologia. 2026. PMID: 41776124. doi:10.1007/s00125-026-06688-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。